● Designing 50+ Hot Sessions of Scientific Forums, Dialogs and Roundtables
● Inviting 500+ Worldwide Distinguished Experts, Investors, and Decision Makers
● Discovery for the Grand Thought Collision from 40+ Countries
● Shooting for 300+ Oral Presentations in Whole Spectrum of Drug Discovery Fields
● Gathering 50+ Posters and Exhibitors in Cutting-edge Technologies and Novel Bioproducts
● Experiencing a Rich Cultural Atmosphere of Kyoto
![]() |
Dr. Yoshinori Ikeura, CEO/CSO, Axcelead Drug Discovery Partners, Inc., Japan | ![]() |
Dr. Matthias von Herrath, Professor, La Jolla Institute; Vice President, NovoNordisk, USA |
![]() |
Dr. Kazuhide Inoue, Professor, Kyushu University, Japan | ![]() |
Dr. Loui Madakamutil, SVP, Head of Discovery, Nektar Therapeutics, USA |
![]() |
Dr. Michael Gamlen, Chief Scientific Officer, Gamlen Tableting Ltd., UK | ![]() |
Dr. Zhuo Li, General Manager, NanoTemper Technologies, China |
![]() |
Dr. Benno Rattel, Executive Director, Nonclinical Development, Amgen Research, Germany | ![]() |
Dr. Jonathan Zalevsky, Senior Vice President, CSO, Research, Nektar Therapeutics, USA | ![]() |
Dr. Alexey RAK, Director of Bio Structure and Biophysics, Sanofi R&D, France |
![]() |
Dr. Tord Labuda, Vice President R&D, LEO Pharma K.K., Japan | ![]() |
Dr. Le Sun, President, AbMax Biotechnology Co., Ltd., China | ![]() |
Dr. Angelito Jonas L. Kalaw, Medical Director, PAREXEL International, Australia |
![]() |
Dr. Balazs Sarkadi, Professor, Semmelweis University, Hungary | ![]() |
Dr. Laszlo Takacs, Professor, University of Debrecen, Hungary |
![]() |
Dr. Yukio Yoneda, Professor Emeritus, Kanazawa University, Japan |
![]() |
Dr. Anthony W. Coleman, Research Director, Université de Lyon, France | ![]() |
Dr. James Legg, Vice President, Research and Development, Crescendo Biologics Ltd., UK | ![]() |
Dr. Meredith Rocca,Senior Scientific Director, Biologics Toxicology, Janssen R & D, USA |
![]() |
Dr. Mircea Ciuca, Global Head Medical & Clinical Drug Safety, Vifor Pharma, Switzerland | ![]() |
Dr. Amrik Basran, CSO, Avacta Life Sciences, UK | ![]() |
Dr. Frank S. Walsh, CEO, Ossianix, Inc., USA |
![]() |
Dr. Karol Jackowski, Professor of Chemistry, University of Warsaw, Poland | ![]() |
Dr. Hiroshi Maruta, Professor, PAK Research Center, Australia | ![]() |
Dr. Yaakov Naparstek, Professor of Medicine, Hadassah University Hospital, Israel |
![]() |
Dr. Richard C Bethell, Chief Scientific Officer, Medivir AB, Sweden | ![]() |
Dr. Aruna Dontabhaktuni, President & CEO, PharmaPro Consulting, USA | ![]() |
Dr. Maria Fardis, President & CEO, Iovance Biotherapeutics, USA |
![]() |
Dr. Richard Denk, Head Sales Containment, SKAN AG, Switzerland | ![]() |
Dr. Robert S. Plumb, Director Omics Sciences, Scientific Operations, Waters Corporation, USA | ![]() |
Dr. Graham R. Ball, Professor/CSO, Nottingham Trent University/CompanDX, UK |
![]() |
Dr. Ilya B. Tsyrlov, President and CSO, Xenotox Inc, USA | ![]() |
Dr. Jacintha Shenton, Scientific Director, Biologics Toxicology, Janssen R&D, USA | ![]() |
Dr. Maier C William, CSO, ICON PLC, UK |
![]() |
Dr. Kang Li, Head of Biologics, BeiGene, China | ![]() |
Dr. Florian Montel, Head of opnMe.com & CNS Project Leader, Boehringer Ingelheim, Germany | ![]() |
Dr. Eiichi Saitoh, Professor, Niigata Institute of Technology, Japan |
![]() |
Dr. Domingo Gargallo-Viola, CSO, ABAC Therapeutics, Spain | ![]() |
Dr. Lee Gethings, Senior Manager, Waters Corporation, UK | ![]() |
Dr. Gail Adinamis, CEO, GlobalCare Clinical Trials, Ltd., USA |
![]() |
Dr. Yinsheng Zhang, Senior Director, Chia Tai Tianqing Pharmaceutical Group Co.,China | ![]() |
Dr. Xiao Feng, President of R&D Center, GeneScience Pharmaceuticals Co., Ltd, China |
![]() |
Dr. Jeffrey Hung, CCO and GM, Vigene Biosciences, USA |
IDDST-2019 provides an ideal platform to showcase your novel technologies and products in Japan. It is developed to offer comfort to delegates while maximizing exhibitor exposure, the coffee breaks and poster sessions will all take place in the exhibition area promoting frequent repeated opportunities for delegates to visit the exhibits.
Why Reserve a Booth at IDDST-2019
• To Meet Face-to-Face with the International Movers and Shakers
• To Meet with Key Decision Marker
• To Explore Business Opportunities
• To Spotlight Advanced Technologies and Their Scientific and Commercial Applications
• To Take Advantage of the Conference's Captive Audience and Networking Opportunities within the Exhibition
Hall
![]() ![]() |
Exhibition Date: |
Kyoto, literally "Capital City", is a city located in the central part of the island of Honshu, Japan. It has a population close to 1.5 million. Kyoto is the most well known capital of Japan in Japanese history for more than one thousand years, it is now the capital city of Kyoto Prefecture located in the Kansai region, as well as a major part of the Kyoto-Osaka-Kobe metropolitan area.
Dr. Yoshinori Ikeura,
CEO/CSO, Axcelead Drug Discovery Partners, Inc., Japan
© 2003-2020 All rights reserved by BIT Group Global Ltd. |